• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON DICKINSON RAY BONANNO CATHETER S/SU; CATHETER AND TUBE, SUPRAPUBIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON DICKINSON RAY BONANNO CATHETER S/SU; CATHETER AND TUBE, SUPRAPUBIC Back to Search Results
Catalog Number 408289
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Hematuria (2558)
Event Date 09/29/2023
Event Type  Injury  
Manufacturer Narrative
Pr (b)(4).Initial mdr submission.A follow up mdr will be submitted if additional information becomes available.Device problem code: a24 - adverse event without identified device or use problem patient problem codes: f08 - hospitalization or prolonged hospitalization.
 
Event Description
This is mdr 2 of 3 (patient 3) customer advised that bladder perforations had occurred with 3 patients following insertion of bonanno suprapubic catheters.These incidents are going to be investigated by the hospital to try to identify if this is product or user related.No lot numbers or samples are available, although these will be tracked for future patients.3x patients with bladder perforations.1 patient also suffered a cardiac arrest.Additional information: 11-oct-2023 - received an email response from complainant for information requested.Answers added in follow up tab.Refer email attached.1.Was there any harm to the patient/caregiver? (detail) patient 1: yes - bladder injury, haematuria, unplanned return to theatre (laparotomy post cardiac arrest), icu admission, extended length of stay (from 4 days to 17days), later re-admission for cystoscopy patient 2: yes ¿ bladder perforation on ct, abdo pain, extended length of stay (from 4 days to 13 days) patient 3: yes ¿ bladder injury, haematuria, unplanned return to theatre (cystoscopy), extended length of stay (from 4 days to 8 days) 2.Did three patients experience bladder perforation and one of those patients experiences cardiac arrest as well? or was there four patients involved? three (3) patients with bladder injury/perforation with one as above requiring icu admission as a result 3.Was there a need for medical and/or surgical intervention due to the incident (imaging tests, surgery, medication administration, etc.)? (detail) yes ¿ patient 1 & patient 3 for return to theatre, all patients had interventions with medication/fluids, patient¿s 1 & 2 had imaging tests 4.Any other actions taken? yes ¿ requested further education from company on product insertion and removal theatre staff now recording lot numbers when opening in theatre to patient medical record isolation of all bonnano spc¿s on removal and held until patient is discharged to aid in qa investigation with manufacturer 5.Any visible damage observed on the product? nil at time of removal however all 3 cases had a delayed effect with symptoms of haematuria etc.Spc¿s had been discarded by this stage and unable to be reviewed 6.How was the catheter inserted?, please provide details/instructions.Vmo surgeon in theatre with over 30 years of experience with these spc¿s ¿ dr (b)(6) cases anterior and posterior vaginal repairs, sacrospinous hitch for prolapse ¿ patient 2 also had vaginal hysterectomy 7.Occurrence date of incident.Patient 1 - (b)(6) 2023.Patient 2 ¿ (b)(6) 2023.Patient 3 --- (b)(6) 2023.
 
Event Description
No additional information received customer advised that bladder perforations had occurred with 3 patients following insertion of bonanno suprapubic catheters.These incidents are going to be investigated by the hospital to try to identify if this is product or user related.No lot numbers or samples are available, although these will be tracked for future patients.3x patients with bladder perforations.1 patient also suffered a cardiac arrest.
 
Manufacturer Narrative
Investigation summary: no sample or photos received by our quality team for investigation.The lot number is unknown, therefore device history record review (dhr) or quality notification review (qn) could not be performed.Bd was not able to confirm customer¿s reported failure.It is important to follow the instructions for use for this product."for proper use, clinicians should be trained in the use of this device.Use the device in conjunction with your facility protocol and reintroduction of the introducer needle must not be attempted.To ensure patient safety, the needle should be handled with care and discarded if damaged.Fluid leakage around the insertion site may indicate catheter damage.Notify the physician immediately.If the bladder is not palpable following pre-procedure preparations, this device should not be used, the procedure should be abandoned, and a foley-type catheter inserted into the bladder through the urethra" in the caution section of the product for catalog 408289 states: "following the introduction of the bonanno catheter, and after the steel puncture needle has been removed, reintroduction of the needle must not be attempted".Based on the quality team's investigation, we are not able to identify a root cause related to our manufacturing process at this time.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
RAY BONANNO CATHETER S/SU
Type of Device
CATHETER AND TUBE, SUPRAPUBIC
Manufacturer (Section D)
BECTON DICKINSON
1 becton drive
franklin lakes NJ 07417
Manufacturer (Section G)
BD CARIBE LTD.
road 31
k.m. 24.3
juncos IA 60061
Manufacturer Contact
helen cox
75 north fairway drive
vernon hills, IL 60061
8473935694
MDR Report Key17938906
MDR Text Key325720855
Report Number2618282-2023-00084
Device Sequence Number1
Product Code FEZ
UDI-Device Identifier00382904082895
UDI-Public(01)00382904082895
Combination Product (y/n)N
Reporter Country CodeAS
PMA/PMN Number
UNK
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Company Representative
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 11/09/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/16/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue Number408289
Device Lot NumberUNKNOWN
Is the Reporter a Health Professional? Yes
Date Manufacturer Received11/09/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
-
-